Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.1 USD | +0.22% | +0.44% | +6.51% |
06/05 | Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6% | MT |
03/05 | JPMorgan Adjusts Price Target on Hologic to $91 From $85 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.51% | 17.72B | |
+7.93% | 219B | |
+7.53% | 183B | |
+15.20% | 136B | |
+27.02% | 107B | |
-1.14% | 63.07B | |
+7.23% | 52.55B | |
+12.58% | 51.28B | |
+1.61% | 41.21B | |
+5.32% | 36.43B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic : Q2 Earnings Gain Trails Estimates, Q3 EPS Guidance Well Below Street View